Evidera
Dori Daroon K. is an accomplished professional with extensive experience in the healthcare and pharmaceutical sectors, currently serving as Senior Director at Evidera. Previous roles include Senior Brand Manager - Oncology at Pierre Fabre Group and Oncology Commercial Insights Lead for the EUCAN region at Takeda. Dori has also held positions at Merck Group, progressing from Associate Brand Manager to Brand Manager, and later serving as Commercial Excellence & Business Insights Manager. Additionally, Dori worked as a Public Health Liaison & Reporting for UNICEF in the Health & Nutrition division. Dori holds a Master of Science (MSc) in Neuroscience and Translational Medicine from Queen Mary University of London, along with a Diploma in Marketing from CIM | The Chartered Institute of Marketing.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.